MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
TZOFEN biological therapeutics
TZOFEN biological therapeutics

Cancer is the second leading cause of death globally. According to the NIH, 18 million new cases, and 10 million deaths recorded in 2018. Two of the most lethal cancer types are pancreatic and liver cancer which harms more than 1 million people worldwide. Based on retroviruses characterize we design a new biological treatment for those cancers. Our novel approach showed the ability to eliminate cancer growth in-vitro and in-vivo. We believe that our treatment will save millions of people lives.
TZOFEN biological therapeutics are developing a novel biological platform for the treatment of various cancers types.

Connect with TZOFEN biological therapeutics

2020

2020 Finalist Israel

Sub industry

Therapeutics (Pharma / Biotech)

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.